Report Detail
Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Growth 2019-2024
- RnM3411955 |
- 13 May, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by "inadequate bone mineralization" (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder.
According to this study, over the next five years the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by product type, application, key manufacturers and key regions and countries.
This study considers the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Control PTH Level
Correct Acidosis
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Akebia
Astellas
Shire
Vifor
Abbvie
Fresenius
Abbott
Novadiol
Japan Tobacco Company
Daiichi-Sankyo
Shield
Spectrum
OPKO
Ardelyx
Sanofi Genzyme
Amgen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by identifying its various subsegments.
Focuses on the key global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption 2014-2024
- 2.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption CAGR by Region
- 2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
- 2.2.1 Control Hyperphosphatemia
- 2.2.2 Maintain Blood Calcium Levels
- 2.2.3 Control PTH Level
- 2.2.4 Correct Acidosis
- 2.2.5 Other
- 2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Type
- 2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2014-2019)
- 2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Drug Stores
- 2.4.5 Other
- 2.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Application
- 2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2014-2019)
3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Manufacturers
- 3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers
- 3.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (2017-2019)
- 3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers (2017-2019)
- 3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturers
- 3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2017-2019)
- 3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturers (2017-2019)
- 3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Manufacturers
- 3.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
- 3.4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base Distribution and Sales Area by Manufacturers
- 3.4.2 Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Regions
- 4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Regions
- 4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Regions
- 4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value by Regions
- 4.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Growth
- 4.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Growth
- 4.4 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Growth
- 4.5 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Growth
5 Americas
- 5.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Countries
- 5.1.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Countries (2014-2019)
- 5.1.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value by Countries (2014-2019)
- 5.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Type
- 5.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Countries
- 6.1.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Countries (2014-2019)
- 6.1.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value by Countries (2014-2019)
- 6.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Type
- 6.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Countries
- 7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Countries (2014-2019)
- 7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value by Countries (2014-2019)
- 7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Type
- 7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Countries
- 8.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Type
- 8.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
- 10.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer
11 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast
- 11.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2019-2024)
- 11.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Regions
- 11.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Regions (2019-2024)
- 11.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type
- 11.8 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application
12 Key Players Analysis
- 12.1 Akebia
- 12.1.1 Company Details
- 12.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Akebia News
- 12.2 Astellas
- 12.2.1 Company Details
- 12.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Astellas News
- 12.3 Shire
- 12.3.1 Company Details
- 12.3.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.3.3 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Shire News
- 12.4 Vifor
- 12.4.1 Company Details
- 12.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Vifor News
- 12.5 Abbvie
- 12.5.1 Company Details
- 12.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Abbvie News
- 12.6 Fresenius
- 12.6.1 Company Details
- 12.6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Fresenius News
- 12.7 Abbott
- 12.7.1 Company Details
- 12.7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Abbott News
- 12.8 Novadiol
- 12.8.1 Company Details
- 12.8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Novadiol News
- 12.9 Japan Tobacco Company
- 12.9.1 Company Details
- 12.9.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Japan Tobacco Company News
- 12.10 Daiichi-Sankyo
- 12.10.1 Company Details
- 12.10.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Offered
- 12.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Daiichi-Sankyo News
- 12.11 Shield
- 12.12 Spectrum
- 12.13 OPKO
- 12.14 Ardelyx
- 12.15 Sanofi Genzyme
- 12.16 Amgen
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) . Industry analysis & Market Report on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is a syndicated market report, published as Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
